Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Muhtasari wa habari
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Fuatilia habari za hivi karibuni kutoka kwa wachapishaji wanaoaminika pamoja na muhtasari mfupi. Fungua chanzo asili kwa maelezo.